Sibi Raj
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Metabolism, Diabetes, and Cancer 4
- Epigenetics and DNA Methylation 3
- Fibroblast Growth Factor Research 2
-
- Cancer, Hypoxia, and Metabolism 6
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Dhruv Kumar (18 shared papers)Kavindra Kumar Kesari (4 shared papers)Ramesh Choudhari (3 shared papers)Janne Ruokolainen (3 shared papers)Mohammad Amjad Kamal (3 shared papers)Bhudev C. Das (2 shared papers)Neha Garg (1 shared paper)Sartaj Khurana (1 shared paper)
- Journals
- Life Sciences (2 papers)Molecular Cancer (1 paper)Nanomedicine (1 paper)Progress in molecular biology and translational science (1 paper)Advances in experimental medicine and biology (1 paper)
- Partner nations
- IndiaUnited StatesUnited Arab Emirates
In The Last Decade
Sibi Raj
18 papers receiving 705 citations
Sibi Raj's Hit Papers
Peers
Comparison fields: 5 of 94
- Biomaterials 179
- Molecular Medicine 25
- Biomedical Engineering 203
- Cancer Research 58
- Infectious Diseases 73
Countries citing papers authored by Sibi Raj
This map shows the geographic impact of Sibi Raj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sibi Raj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sibi Raj more than expected).
Fields of papers citing papers by Sibi Raj
This network shows the impact of papers produced by Sibi Raj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sibi Raj. The network helps show where Sibi Raj may publish in the future.
Co-authors
The 25 scholars most cited alongside Sibi Raj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy Hit paper breakdown → | 2019 | 351 |
| 2 | 2022 | 117 | |
| 3 | In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach | 2020 | 58 |
| 4 | 2020 | 42 | |
| 5 | 2020 | 37 | |
| 6 | 2020 | 27 | |
| 7 | 2021 | 20 | |
| 8 | 2020 | 13 | |
| 9 | 2021 | 12 | |
| 10 | 2020 | 11 | |
| 11 | 2020 | 9 | |
| 12 | 2021 | 7 | |
| 13 | 2022 | 5 | |
| 14 | 2023 | 2 | |
| 15 | 2020 | 2 | |
| 16 | 2020 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2023 | 0 |
About Sibi Raj
Sibi Raj is a scholar working on Molecular Biology, Cancer Research, Infectious Diseases, Biomedical Engineering and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 718 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (6 papers), Metabolism, Diabetes, and Cancer (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Epigenetics and DNA Methylation (3 papers), Liver physiology and pathology (2 papers), Cancer, Lipids, and Metabolism (2 papers), Computational Drug Discovery Methods (2 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Biomaterials (179 citations), Molecular Medicine (25 citations), Biomedical Engineering (203 citations), Cancer Research (58 citations) and Infectious Diseases (73 citations). Sibi Raj has collaborated with scholars based in India, United States and United Arab Emirates. Frequent co-authors include Dhruv Kumar, Kavindra Kumar Kesari, Ramesh Choudhari, Janne Ruokolainen, Mohammad Amjad Kamal, Bhudev C. Das, Neha Garg, Sartaj Khurana, Brijesh Rathi and Niraj Kumar Jha. Their work appears in journals such as Life Sciences, Molecular Cancer, Nanomedicine, Progress in molecular biology and translational science and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.